title: [Diabetes mellitus. SGLT2 inhibitor reduces cardiovascular mortality].
authors.forename: Peter
authors.initials: P
authors.lastname: Overbeck
mesh_terms: D006801:Humans; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000401:mortality / Q000517:prevention & control; D002423:Cause of Death; D003131:Combined Modality Therapy; D003925:Diabetic Angiopathies / Q000401:mortality / Q000517:prevention & control; D005960:Glucosides / Q000627:therapeutic use; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D015996:Survival Rate
chemical_list: D001559:Benzhydryl Compounds; C570240:empagliflozin; D005960:Glucosides; C089180:SLC5A2 protein, human; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors